Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Cellyan Biotechnology CoHKPD -13.55%18 Days Inventory is 14.89 as of Mar. 2026, which is 2% above its 10-year median of 14.58. GuruFocus rates HKPD with a GF Score™ of 18/100. The stock has 3 warning signs investors should review. Among 117 Medical Distribution companies, Cellyan Biotechnology Co ranks better than 94.02% on this metric.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Cellyan Biotechnology Co's Inventory Turnover for the
six
months ended in Mar. 2026 was 12.26.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Cellyan Biotechnology Co's Inventory-to-Revenue for the
six
months ended in Mar. 2026 was 0.08.
Cellyan Biotechnology Co (NAS:HKPD) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Cellyan Biotechnology Co's Inventory Turnover for the
six
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Cellyan Biotechnology Co's Inventory to Revenue for the
six
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Cellyan Biotechnology Co Days Inventory Related Terms
Cellyan Biotechnology Co Days Inventory Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HKPD vs MEDS, COSM, SNYR: Days Inventory Comparison
For the Medical Distribution subindustry, Cellyan Biotechnology Co's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cellyan Biotechnology Co Days Inventory vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Cellyan Biotechnology Co's Days Inventory distribution charts can be found below:
* The bar in red indicates where Cellyan Biotechnology Co's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cellyan Biotechnology Co (HKPD) has a Days Inventory of 14.89 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Cellyan Biotechnology Co and its competitors. This is near median its historical median of 14.58. Over the past decade, Cellyan Biotechnology Co's Days Inventory has ranged from 7.10 to 15.62. According to the industry distribution chart, Cellyan Biotechnology Co ranks #7 out of 117 companies in the Medical Distribution industry, placing it in the top 6%.
Is Cellyan Biotechnology Co's Days Inventory too high?
Cellyan Biotechnology Co's current Days Inventory of 14.89 is near median its 10-year median of 14.58. Over the past 10 years, this metric has ranged from a low of 7.10 to a high of 15.62. The Medical Distribution industry median Days Inventory is 54.88. Cellyan Biotechnology Co's value of 14.89 is 72.9% below this industry median. Based on the distribution chart, Cellyan Biotechnology Co ranks #7 out of 117 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers. Overall, Cellyan Biotechnology Co has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Cellyan Biotechnology Co's Days Inventory compare to MEDS and COSM?
According to the Medical Distribution industry distribution chart, Cellyan Biotechnology Co ranks #7 out of 117 companies for Days Inventory. This places Cellyan Biotechnology Co in the top 6% of its industry — outperforming the majority of peers. The industry median Days Inventory is 54.88. Cellyan Biotechnology Co's value of 14.89 is 72.9% below this benchmark. Historically, Cellyan Biotechnology Co's own Days Inventory has ranged from 7.10 to 15.62 over the past decade. While the company's 10-year median is 14.58 vs. the industry median of 54.88, Cellyan Biotechnology Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Medical Distribution company?
The median Days Inventory among Medical Distribution companies is 54.88, based on 117 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Cellyan Biotechnology Co's current Days Inventory of 14.89 is 72.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Cellyan Biotechnology Co and its competitors. For the Medical Distribution industry, the median Days Inventory is 54.88 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cellyan Biotechnology Co's current Days Inventory is 14.89, which is near median its own 10-year median of 14.58. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cellyan Biotechnology Co stock overvalued right now?
Cellyan Biotechnology Co (HKPD) has a current Days Inventory of 14.89. The current Days Inventory is 14.89, which is near median its 10-year median of 14.58 and 72.9% below the Medical Distribution industry median of 54.88. Cellyan Biotechnology Co's overall GF Score™ is 18/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Cellyan Biotechnology Co (HKPD), the current Days Inventory is 14.89 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Cellyan Biotechnology Co Ltd formerly, Hong Kong Pharma Digital Technology Holdings Ltd operates in two main categories: OTC pharmaceutical cross-border e-commerce supply chain services, conducted through its Hong Kong subsidiary, Joint Cross Border, which it refers to as the Supply Chain Services division, and OTC pharmaceutical cross-border procurement and distribution, conducted through its Hong Kong subsidiary, V-Alliance, which it referred to as the Procurement and Distribution division. Based in Hong Kong, Joint Cross Border has established itself as a provider of third-party supply chain services in Mainland China's OTC pharmaceutical cross-border e-commerce market.
18GF Score
Get the complete analysis for HKPD
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKPD has been successfully added to your 
